From: Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients
Par. | Test 1 | Test 2 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | 1 year time-point | 3 year time-point |  | 1 year time-point | 3 year time-point |  | ||||||||
 | Med | 25 th | 75 th | Med | 25 th | 75 th | P | Med | 25 th | 75 th | Med | 25 th | 75 th | P |
BD | 3.98 | 3.69 | 4.02 | 3.79 | 3.64 | 4.35 | 0.66 | 3.65 | 3.41 | 4.01 | 3.97 | 3.39 | 4.22 | 0.32 |
MA | 3.55 | 3.40 | 3.72 | 3.67 | 3.47 | 4.08 | 0.08 | 3.38 | 3.09 | 3.62 | 3.49 | 3.03 | 3.96 | 0.03 |
RA | 0.23 | 0.05 | 0.46 | 0.16 | 0.03 | 0.24 | 0.15 | 0.32 | 0.12 | 0.62 | 0.30 | 0.19 | 0.44 | 0.57 |
PC | 0.94 | 0.89 | 0.98 | 0.96 | 0.94 | 0.99 | 0.12 | 0.91 | 0.84 | 0.96 | 0.92 | 0.89 | 0.95 | 0.57 |
RT | 0.62 | 0.48 | 0.82 | 0.66 | 0.58 | 0.84 | 0.24 | 0.90 | 0.66 | 1.18 | 0.98 | 0.64 | 1.12 | 0.96 |
CV | 0.38 | 0.10 | 0.65 | 0.22 | 0.04 | 0.46 | 0.11 | 0.33 | 0.13 | 0.66 | 0.32 | 0.22 | 0.42 | 0.67 |